NovaBay Pharmaceuticals, Inc. Logo

NovaBay Pharmaceuticals, Inc.

Develops and commercializes eyecare, skincare, and wound care products.

NBY | US

Overview

Corporate Details

ISIN(s):
US66987P2011
LEI:
Country:
United States of America
Address:
2000 POWELL STREET, SUITE 1150, 94608 EMERYVILLE

Description

NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company that develops and commercializes scientifically-created and clinically-proven products for the eyecare, skincare, and wound care markets. The company's core technology is a proprietary, stable formulation of hypochlorous acid. Its leading product is Avenova®, an antimicrobial lid and lash solution available over-the-counter for eye hygiene. In the wound care sector, NovaBay manufactures and sells products under the NeutroPhase® and PhaseOne® brands, which utilize its hypochlorous acid technology to aid in cleansing and debridement. The company focuses on providing accessible, problem-solving solutions for improved well-being.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all NovaBay Pharmaceuticals, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for NovaBay Pharmaceuticals, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for NovaBay Pharmaceuticals, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

DAEWOONG PHARMA Logo
Develops and manufactures drugs, biologics, and active pharmaceutical ingredients.
South Korea
069620
DAIICHI SANKYO COMPANY, LIMITED Logo
A global healthcare company that researches and develops novel pharmaceutical solutions.
Japan
4568
Daito Pharmaceutical Co., Ltd. Logo
Integrated manufacturer of APIs and finished drugs for generic and OTC markets.
Japan
4577
Dare Bioscience, Inc. Logo
A clinical-stage biopharmaceutical company advancing innovative products for women's health.
United States of America
DARE
Day One Biopharmaceuticals, Inc. Logo
Commercial-stage company developing targeted cancer therapies, focusing on pediatrics.
United States of America
DAWN
DBV Technologies Logo
Develops epicutaneous immunotherapy (EPIT) patch technology for food allergies.
France
DBV
DBV Technologies S.A. Logo
A clinical-stage company developing epicutaneous immunotherapy for food allergies.
United States of America
DBVT
D&D Pharmatech Inc. Logo
Clinical-stage biopharma developing GLP-1 therapies for metabolic and neurodegenerative diseases.
South Korea
347850
Dechra Pharmaceuticals PLC Logo
A global specialist in veterinary pharmaceuticals and related products.
United Kingdom
DPH
DELCATH SYSTEMS, INC. Logo
Interventional oncology company treating liver cancers with targeted chemotherapy.
United States of America
DCTH

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.